HIV vaccine trials are complicated by the availability of PrEP

Photo of Holly Janes
Fred Hutchinson Cancer Research Center Hutch News

Affiliate Professor of Biostatistics and Fred Hutch biostatistician Holly Janes participated in discussions about the design of HIV vaccine trails in the era of oral PrEP. “There are a lot of people who are interested in PrEP, but cannot sustain that over time,” she said. “One reason has to do with the usual challenges of getting people to change their behaviors when they are healthy. An analogy might be the difficulty in getting people to floss their teeth on a daily basis. It’s difficult for all of us,” said Janes.

Category